Generator: | SimpleRSS ver 0.4 (BlueHippo) Release 1 |
Docs: | http://blogs.law.harvard.edu/tech/rss |
Published on:�April 17, 2018 (WASHINGTON, April 18, 2018) � Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study. The�study, published online today in�Blood Advances, a...
The post For Young Adults with Blood Cancer, Pediatric Centers May Improve Survival appeared first on Medical Arts Laboratory - Florida Blood Lab | Blood Draw & Test.
Publish date:�June 7, 2018 By�Christopher Palmer��Hematology News The�Food and Drug Administration has approved methoxy polyethylene glycol-epoetin beta (Mircera) for the treatment of dialysis-related anemia in pediatric�patients aged 5-17 years with chronic kidney disease whose hemoglobin had been stabilized with an erythropoiesis-stimulating agent (ESA). The approval...
The post FDA approves long-acting ESA for dialysis-related anemia in children, adolescents appeared first on Medical Arts Laboratory - Florida Blood Lab | Blood Draw & Test.